The trademark application TRANSFORMING PATIENT CARE was filed by GeneOhm Sciences, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on October 5, 2008, and it was registered by office on February 18, 2009 without any oppositions.
The application was filed in English (German was selected as the second language).
The renewal of the trademark was recorded by the office on December 3, 2016.
of the trademark registration was recorded on December 3, 2016. Appointment and Replacement of representative of the trademark registration was recorded on March 9, 2006. Change of name and professional address of the trademark registration was recorded on August 19, 2007. Change of name and professional address of the trademark registration was recorded on August 24, 2008. Change of name and professional address of the trademark registration was recorded on February 6, 2011. Change of name and professional address of the trademark registration was recorded on March 17, 2011. Change of name and professional address of the trademark registration was recorded on September 14, 2014.
The Refusal with reference B 004882759 was partially rejected according to Article 7(1)(b) CTMR with decision issued on February 27, 2007 by the EUIPO.
Goods And Services
The mark was filed in class 1 with following description of goods:
Reagents consisting of nucleic acid(s), oligonucleotides and analogs and derivatives thereof, polynucleotides, nucleotides, standards, controls, chemical reagents, buffers for biomedical and research applications
Reagents and/or diagnostic kits for the detection of genetic markers including
Snps, mutations, deletions, and insertions
Reagents and diagnostic kits for the detection of nucleic acid(s)
Scientific products including biological reagents, genetic material, oligonucleotides, polynucleotides, standars, controls, chemical reagents and buffers useful for charecterizing nucleic acid(s) and for scientific research.
The mark was filed in class 5 with following description of goods:
Medical products including biological reagents, genetic material, oligonucleotides, polynucleotides, standards, controls, chemical reagents and buffers useful for characterizing nucleic acid(s) and for scientific research
Reagents and/or diagnostic kits for the detection of genetic markers including
Snps, mutations, deletions, and insertions
Reagents and diagnostic kits for the detection of nucleic acid(s).
The mark was filed in class 9 with following description of goods:
Integrated circuits and microelectronic chips for analyzing and characterizing nucleic acid(s) for medical and research applications
Software for the analysis of data generated from assays of nucleic acid(s) for medical and research applications
Instruments and tools for the analysis of nucleic acid(s) for scientific and laboratory purposes.
The mark was filed in class 10 with Instruments and tools for the analysis of nucleic acid(s) for medical applications.